🇺🇸 FDA
Pipeline program

Acetadote

STU20250529; SCCC-07325

Phase 1 small_molecule active

Quick answer

Acetadote for Glioblastoma is a Phase 1 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Glioblastoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials